(S (NP-SBJ (JJ Human) (NN CD4) (NNS lymphocytes)) (ADVP (RB specifically)) (VP (VBP recognize) (NP (NP (DT a) (NN peptide)) (VP (VBG representing) (NP (NP (DT the) (NN fusion) (NN region)) (PP (IN of) (NP (NP (DT the) (NN hybrid) (NN protein) (NN (RAR pml)) (NN alpha)) (ADJP (JJ present) (PP (IN in) (NP (JJ acute) (JJ promyelocytic) (NN leukemia) (NNS cells)))))))))) (. .))
(S (NP-SBJ (NP (NN Fusion) (NNS proteins)) (ADJP (JJ present) (PP (IN in) (NP (JJ leukemic) (NNS cells))))) (ADVP-TMP (RB frequently)) (VP (VBP contain) (NP (DT a) (JJ new) (NN amino) (NN acid)) (PP (IN at) (NP (DT the) (NN fusion) (NN point)))) (. .))
(S (NP-SBJ (PRP We)) (VP (VBD tested) (SBAR (IN whether) (S (NP-SBJ-51 (NP (NP (DT a) (NN peptide)) (PRN (-LRB- -LRB-) (NP (NN (25 BCR1))) (-RRB- -RRB-))) (VP (VBG encompassing) (NP (NP (DT the) (NN fusion) (NN region)) (PP (IN of) (NP (DT the) (NN hybrid) (NN molecule) (NN (RAR pml)) (NN alpha))))) (, ,) (SBAR (WHNP-52 (WDT which)) (S (NP-SBJ-53 (-NONE- *T*-52)) (VP (VBZ is) (VP (ADVP (RB selectively)) (VBN expressed) (NP (-NONE- *-53)) (PP (IN by) (NP-LGS (NP (NP (JJ acute) (JJ promyelocytic) (NN leukemia)) (PRN (-LRB- -LRB-) (NP (NN APL)) (-RRB- -RRB-))) (NNS cells))))))) (, ,)) (VP (MD can) (VP (VB be) (VP (VBN recognized) (NP (-NONE- *-51)) (PP (IN by) (NP-LGS (JJ human) (NN T) (NNS lymphocytes))) (ADVP (FW in) (FW vitro)))))))) (. .))
(S (NP-SBJ (NP (JJ CD4+) (NNS lymphocytes)) (, ,) (PP (IN at) (NP (ADJP-COOD (CC both) (ADJP (JJ polyclonal)) (CC and) (ADJP (JJ clonal))) (NN level))) (, ,)) (VP (VBD recognized) (NP (NN peptide) (NN (25 BCR1))) (PP (IN in) (NP (DT an) (JJ HLA-DR--restricted) (NN fashion))) (PP (IN on) (NP (NP (NN presentation)) (PP-COOD (PP (IN by) (NP (JJ autologous) (NP (NP (JJ antigen-presenting) (NN cell)) (PRN (-LRB- -LRB-) (NP (NN APC)) (-RRB- -RRB-))))) (CC or) (PP (IN by) (NP (NP (NN APC)) (VP (VBG expressing) (NP (DT the) (NN HLA-DR11) (NN restricting) (NN molecule))))))))) (. .))
(S (NP-SBJ-54 (NP (NN Control) (NNS peptides)) (VP (VBG corresponding) (PP (TO to) (NP (DT the) (NP-COOD (NP (JJ normal) (NN pml)) (CC and) (NP (NN RAR) (NN alpha))) (NNS proteins))))) (VP (VBD were) (RB not) (VP (VBN recognized) (NP (-NONE- *-54)))) (. .))
(S (NP-SBJ (NP (CD One) (NN clone)) (PRN (-LRB- -LRB-) (NP (NN DEG5)) (-RRB- -RRB-))) (ADVP (RB also)) (VP (VBD exerted) (NP (NP (DT a) (ADJP-COOD (ADJP (JJ high)) (CC and) (ADJP (JJ specific))) (NN cytotoxicity)) (PP (IN against) (NP (NP (JJ autologous) (NNS cells)) (VP (VBN pulsed) (NP (-NONE- *)) (PP (IN with) (NP (NN (25 BCR1))))))))) (. .))
(S (NP-SBJ (NP (DT The) (JJ autologous) (NN DE) (NN LCL)) (VP-COOD (VP (VBG containing) (NP (DT a) (VBN transduced) (NN (RAR pml)) (NN alpha) (NN fusion) (NN gene))) (CC and) (VP (VBG expressing) (NP (NP (DT a) (NN bcr1) (NN type)) (PP (IN of) (NP (DT the) (NN (RAR pml)) (NN alpha) (NN hybrid) (NN protein))))))) (VP (VBD induced) (NP (NP (DT the) (NN proliferation)) (PP (IN of) (NP (NN DE) (CD (25 anti-BCR1)) (NN T) (NN cell) (NNS clones))))) (. .))
(S (NP-SBJ (PRP It)) (VP (VBZ is) (VP (VBN concluded) (SBAR (IN that) (S (NP-SBJ (NP (DT the) (NN bcr1) (NN (RAR type-pml)) (NN alpha) (NN fusion) (NN protein)) (PP (IN of) (NP (NN APL)))) (VP (VBZ contains) (NP (NP (DT an) (JJ antigenic) (NN site)) (, ,) (UCP-COOD (ADJP (JJ absent) (PP (IN from) (NP (DT the) (JJ normal) (NN parent) (NNS molecules)))) (CC and) (VP (VBN recognized) (NP (-NONE- *)) (PP (IN by) (NP-LGS (JJ human) (JJ CD4+) (NNS lymphocytes))))))))))) (. .))
